Recro Pharma, Inc. (REPH) Social Stream
Recro Pharma Inc (REPH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering REPH.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 29 weeks, REPH's average price target has gone down $0.5.
Over the past 34 weeks, REPH's average upside potential has been 118.94%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
REPH Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Recro Pharma Inc's variance in analysts' estimates is lower than just about 100% of all US stocks.
- In the context of Healthcare stocks, Recro Pharma Inc's number of analysts covering the stock is greater than 4.65% of them.
- In the context of Healthcare stocks, Recro Pharma Inc's average analyst price target is greater than 5.18% of them.
- Recro Pharma Inc's upside potential (average analyst target price relative to current price) is higher than 62.5% of stocks in the small market cap category.
Is REPH a Buy, Hold or Sell? See the POWR Ratings now!